|
||||||||||||||||||
Data:2009-12-12 2:34
Source: Industrial Equity Research
Jianteshengwu (000,416) is a pharmaceutical manufacturing unit, the company main business is the retail health care products. Company's recent restructuring, reorganization plans, the main concern about stock brokers. Investors may in the short-term intervention.
Historical Information: Jianteshengwu (000,416): the impact of early afternoon the possibility of a great new high June 28, 2006
Source: Wuhan New Rand
Jianteshengwu (000,416) of the share reform program of the delay introduced, and the company's largest shareholders, substantial flow of the attitude of a great association. Zhongguancun securities Jianteshengwu's largest circulation shareholder, Zhongguancun section of Wing Kei, who is also chairman of the Securities and Zhongguancun Science and Technology Development (Holding) Co., Ltd. General Manager is also the chairman of Stone Group. According to the latest news, Jianteshengwu of the share reform program is in full swing in the formulation of which, the company will seek to share reform before the end of June. The progress under the current term, to achieve this goal should be no major problems.Jianteshengwu (000,416): results of the pre-fall 50% May 3, 2006
Source: Shanghai Securities News Authors: Jun Cai Yi
Jianteshengwu expects 2006 net profit of 1-6 months to achieve than the cumulative decline in more than 50% a year earlier.